Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus

Prospective analysis of B cell subset dynamics following telitacicept treatment in systemic lupus erythematosus

Abstract Background Systemic lupus erythematosus (SLE) is an autoimmune inflammatory disease marked by B cell activation and autoantibody formation. Telitacicept, a dual inhibitor of the B cell pathway, neutralizes signals from B lymphocyte stimulator and a proliferation-inducing ligand. The aim of...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaowei Chen, Lingzhen Hu, Lingxiao Zhu, Jianxin Tu, Jiajun Gui, Mengyuan Fang, Li Sun
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Arthritis Research & Therapy
Subjects:
Systemic lupus erythematosus
B cell subsets
Telitacicept
Online Access:https://doi.org/10.1186/s13075-025-03584-x
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items